,headline,final_score,datetime
0,aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting,57,2023-04-17 05:00:00
1,aTyr Pharma (LIFE) Receives a Buy from H.C. Wainwright,86,2023-04-17 04:05:00
2,aTyr Pharma presents preclinical research on treatment with ATYR2810 at AACR,86,2023-04-17 00:08:00
3,Piper Sandler Maintains aTyr Pharma (LIFE) Overweight Recommendation,86,2023-04-11 14:41:58
4,aTyr Pharma price target raised to $13 from $9 at Piper Sandler,86,2023-04-11 00:05:00
5,"aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases",57,2023-03-30 05:00:00
6,aTyr Pharma announces first major review article for Efzofitimod,86,2023-03-30 00:14:00
10,Here's Why We're Watching aTyr Pharma's (NASDAQ:LIFE) Cash Burn Situation,86,2023-03-23 04:10:06
11,aTyr Pharma to Present Data Identifying Fibrosis Target for tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis Pathogenesis and Resolution,57,2023-03-21 05:00:00
12,aTyr Pharma to present data from tRNA synthetase candidate ATYR0101,86,2023-03-21 00:18:00
13,aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies,57,2023-03-20 05:00:00
14,JonesTrading Keeps Their Buy Rating on aTyr Pharma (LIFE),86,2023-03-12 23:55:00
15,"aTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call Transcript",86,2023-03-10 09:12:09
17,"Analysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), COMPASS Pathways (CMPS) and Olema Pharmaceuticals (OLMA)",60,2023-03-09 21:20:00
18,"Atyr Pharma (LIFE) Reports Q4 Loss, Tops Revenue Estimates",86,2023-03-09 14:15:10
19,aTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update,86,2023-03-09 13:00:00
20,Atyr Pharma: Q4 Earnings Snapshot,86,2023-03-09 08:17:00
21,"aTyr Pharma GAAP EPS of -$0.26 beats by $0.22, revenue of $10.4M beats by $10.15M",86,2023-03-08 19:08:00
22,aTyr Pharma to Present at March Investor Conferences,86,2023-03-08 05:00:00
24,aTyr Pharma resumed with a Buy at Roth MKM,86,2023-03-06 00:19:00
